Glutathione S-transferase variants in a Brazilian population

Pharmacology

Volumn 83, Issue 4, 2009, Pages 231-236

  Magno, Luiz Alexandre V ^a   Talbot, Jhimmy ^a   Talbot, Teddy ^a   Borges Santos, Alex Marques ^a   Souza, Renan P ^b   Marin, Lauro J ^a   Moreli, Marcos Lázaro ^a   De Melo, Paulo R S ^a   Corrêa, Ronan X ^a   Rios Santos, Fabrício ^a   Di Pietro, Giuliano ^a  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Glutathione S transferases; Metabolic enzymes; Pharmacogenetics

Indexed keywords

ENZYME VARIANT; GLUTATHIONE TRANSFERASE; ISOLEUCINE; VALINE;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; BRAZIL; CAUCASIAN; ETHNIC GROUP; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HETEROZYGOSITY; HUMAN; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NORMAL HUMAN; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AFRICAN AMERICANS; BRAZIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INDIANS, SOUTH AMERICAN; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 64149129765     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000205823     Document Type: Article

References (38)

1. Cargill M, Altshuler D, Ireland J, et al: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-238.
2. Vasiliou V, Pappa A: Polymorphisms of human aldehyde dehydrogenases consequences. Pharmacolog y 2000; 61: 192-198.
3. Boyer TD: The glutathione S-transferases: an update. Hepatology 1989; 9:486-496.
4. Gulick AM, Fahl WE: Forced evolution of glutathione S-transferase to create a more efficient drug detoxification enzyme. Proc Natl Acad Sci USA 1995; 92:8140-8144.
5. Seidegard J, Ekström G: The role of human glutathione S-transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 1997; 105:791-799.
6. Hayes JD, Strange RC: Glutathione S-trans-ferase polymorphisms and their biological consequences. Pharmacolog y 2000; 61: 154-166.
7. Eaton DL, Bammler TK: Concise review of the glutathione S-transferases and their significance to toxicolog y. Tox icol Sci 1999; 49: 156-164.
8. Strange RC, Spiteri MA, Ramachandran S, et al: Glutathione-S-transferase family of enzymes. Mutat Res 2001; 482:21-26.
9. Hirvonen A: Genetic factors in individual responses to environmental exposures. J Occup Environ Med 1995; 37:37-43.
10. Wiencke JK, Kelsey KT, Lamela RA, et al: Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-in-duced cytogenetic damage. Cancer Res 1990; 50: 1585-159 0.
11. Norppa H, Hirvonen A, Järventaus H, et al: Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxy-butane in cultured human lymphocytes. Carcinogenesis 1995; 16:1261-1264.
12. Anderer G, Schrappe M, Brechlin AM, et al: Polymorphisms within glutathione S-trans-ferase genes and initial response to glucocor-ticoids in childhood acute lymphoblastic leukemia. Pharmacogenetics 2000; 10:715-726.
13. Dasgupta RK, Adamson PJ, Davies FE, et al: Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. Blood 2003; 102: 2345-2350.
14. Hayes JD, Flanagan JU, Jowsey IR: Glutathi-one transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
15. Mannervik B, Alin P, Guthenberg C, et al: Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985; 82: 7202-7206.
16. Pemble S, Schroeder KR, Spencer TSR, et al: Human glutathione S-transferase theta (GSTT1 ): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-276.
17. Steiner C, Peters WH, Gallagher EP, et al: Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-di-hydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system. Carcinogenesis 2007; 28:738-748.
18. Rojas M, Cascorbi I, Alexandrov K, et al: Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis 2000; 21:35-41.
19. Ali-Osman F, Akande O, Antoun G, et al: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-trans-ferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272:10004-10012.
20. Watson MA, Stewart RK, Smith GB, et al: Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19:275-280.
21. Koseler A, Ilcol YO, Ulus IH: Frequency of mutated allele CYP2D6*4 in the Turkish population. Pharmacology 2007; 79:203-206.
22. Wood AJ J: Racia l dif ferences in t he response to drugs - pointers to genetic differences. N Engl J Med 2001; 344:1393-1396.
23. Huang N, Agrawal V, Giacomini KM, Miller WL: Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci USA 2008; 105: 1733-1738.
24. Solus JF, Arietta BJ, Harris JR, et al: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 2004; 5:895-931.
25. Bolt HM, Thier R: Relevance of the deletion polymorphisms of the glutathione S-trans-ferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006; 7: 613-628.
26. Parra FC, Amado RC, Lambertucci JR, et al: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003; 100:177-182.
27. Vieira AR, Karras JC, Orioli IM, et al: Genetics origins in a South American clefting population. Clin Genet 2002; 62:458-463.
28. Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW: A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996; 107: 229-233.
29. Harris MJ, Coggan M, Langton L: Polymorphism of the Pi class glutathione S-transfer-ase in normal populations and cancer patients. Pharmacogenetics 1998; 8:27-31.
30. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25:115-121.
31. Souza RP, Romano-Silva MA, Lieberman JA, et al: Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) 2008; 200:177-186.
32. Falush D, Stephens M, Pritchard JK: Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol 2007; 7:574-578.
33. Garte S, Gaspari L, Alexandrie AK, et al: Metabolic gene polymorphism frequencies in control populations. Can Epidemiol Biomarkers Prev 2001; 10:1239-1248.
34. Liggett SB: Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000; 61: 167-173.
35. Zembrzuski VM, Callegari-Jacques SM, Hutz MH: Application of an African Ancestry Index as a genomic control approach in a Brazilian population. Ann Hum Genet 2006; 70: 822-828.
36. Carvalho-Silva DR, Santos FR, Rocha J, Pena SDJ: The phylogeography of Brazilian Y-chromosome lineages. Am J Genet 2001; 68: 281-286.
37. Arruda VR, Grignolli CE, Gonçalves MS, et al: Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis? Clin Genet 1998; 54:210-214.
38. Suarez-Kurtz G, Vargens DD, Struchiner CJ, et al: Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms. Pharmacogenet Genomics 2007; 17: 765-771.